Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00519025 · ClinicalTrials.gov registry record
Risk Factors for Linezolid Resistance in Staphylococcus Aureus
A clinical trial of Staphylococcus Aureus and Linezolid Resistance, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 360
- Enrollment target
- 1
- Study location
NCT00519025: Completed study of Staphylococcus Aureus and Linezolid Resistance, sponsored by University of Pittsburgh.
NCT00519025 is a study of Staphylococcus Aureus and Linezolid Resistance that has completed, run by University of Pittsburgh. The registered enrollment target is 360 participants, below the 3,859-participant average among 8 other Staphylococcus Aureus trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00519025, a study of Staphylococcus Aureus and Linezolid Resistance, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 360 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a retrospective chart review study. The proposed study aims to document the risk factors for quinolone resistance in bloodstream isolates of Klebsiella species. Additionally, the adequacy of empiric antibiotic therapy for Klebsiella bloodstream infections will be assessed.
Conditions Studied
Study Locations (1)
Pennsylvania
- University of Pittsburgh Medical Center - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 360 participants |
| Start Date | 2007-08 |
| Est. Completion | 2017-06 |
What the finished NCT00519025 record still lists
NCT00519025 is an observational study that tracks outcomes without assigning an intervention. The registered 360 participants enrollment target is mid-sized for trials with a published cap, below the 3,859-participant average among 8 other Staphylococcus Aureus trials with a reported enrollment target (91% lower).
The record links to 2 conditions, with Staphylococcus Aureus appearing as the primary indexed condition, and to 0 interventions.
NCT00519025 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00519025 about?
NCT00519025 is a clinical study titled "Risk Factors for Linezolid Resistance in Staphylococcus Aureus". This is a retrospective chart review study. The proposed study aims to document the risk factors for quinolone resistance in bloodstream isolates of Klebsiella species. Additionally, the adequacy of empiric antibiotic therapy for Klebsiella bloodstream infections will be assessed.
What is the current status of trial NCT00519025?
This trial is currently completed. The enrollment target is 360 participants. The study started on 2007-08. Estimated completion is 2017-06.
What conditions does trial NCT00519025 study?
This clinical trial studies the following conditions: Staphylococcus Aureus, Linezolid Resistance.
Who is sponsoring clinical trial NCT00519025?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00519025 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Staphylococcus Aureus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00519025's enrollment target sits among peer trials
360 2nd of 8 the highest of 8 other Staphylococcus Aureus trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Staphylococcus Aureus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Comparing Single Versus Repeat NMT on the Diversity of the Neonatal Nasal Microbiome
RECRUITING · Phase 1
-
A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa)
RECRUITING · Phase 1
-
Interleukin-4Ra Blockade by Dupilumab Decreases Staphylococcus Colonization and Increases Microbial Diversity in CRSwNP
RECRUITING · Phase 4
-
Feasibility and Safety Study of Parent-to-Child Nasal Microbiota Transplant
ACTIVE NOT RECRUITING · Phase 1
-
A Prospective Cohort Pilot Study of the Clinical and Molecular Epidemiology of Staphylococcus Aureus in Pregnant Women at the Time of Group B Streptococcal Screening in a Large Urban Medical Center in Chicago, IL USA
COMPLETED · NA
-
Methicillin-resistant Staphylococcus Aureus (MRSA) Skin and Soft Tissue Infection (SSTI) Prevention in Military Trainees
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02747836 · 360 participants
Ultrasound Analysis of Human Carpal Tunnel System
- NCT04089046 · 360 participants · NA
Telemedicine Enhanced Asthma Management - Uniting Providers for Teens (TEAM-UP for Teens)
- NCT04130503 · 360 participants · NA
The Recovery in Stroke Using PAP Study
- NCT04160000 · 360 participants · Phase 4
Treatment Of Atrial Fibrillation In Preserved Cardiac Function Heart Failure
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia